Diagnosing obesity by body mass index in chronic kidney disease: An explanation for the "obesity paradox?"

Rajiv Agarwal, Jennifer E. Bills, Robert P. Light

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Although obesity is associated with poor outcomes, among patients with chronic kidney disease (CKD), obesity is related to improved survival. These results may be related to poor diagnostic performance of body mass index (BMI) in assessing body fat content. Accordingly, among 77 patients with CKD and 20 controls, body fat percentage was estimated by air displacement plethysmography (ADP), skinfold thickness, and body impedance analysis. Defined by BMI ≥30 kg/m, the prevalence of obesity was 20% in controls and 65% in patients with CKD. Defined by ADP, the prevalence increased to 60% among controls and to 90% among patients with CKD. Although sensitivity and positive predictive value of BMI to diagnose obesity were 100%, specificity was 72%, but the negative predictive value was only 30%. BMI correctly classified adiposity in 75%. Regardless of the presence or absence of CKD, subclinical obesity (defined as BMI <30 kg/m but excess body fat by ADP) was often missed in people with low lean body mass. The adjusted odds ratio for subclinical obesity per 1 kg of reduced lean body mass by ADP was 1.14 (95% CI: 1.06 to 1.23; P<0.001). Skinfold thickness measurements correctly classified 94% of CKD patients, but bioelectrical impedance analyzer-assessed body fat estimation did so in only 65%. Air displacement plethysmography-, skinfold thickness-, and bioelectrical impedance analyzer-assessed body fat all provided reproducible estimates of adiposity. Skinfold thickness measurements may be a better test to classify obesity among those with CKD. Given the low negative predictive value of BMI for obesity, our study may provide an explanation of the "obesity paradox."

Original languageEnglish
Pages (from-to)893-900
Number of pages8
JournalHypertension
Volume56
Issue number5
DOIs
StatePublished - Nov 2010

Fingerprint

Chronic Renal Insufficiency
Body Mass Index
Obesity
Plethysmography
Skinfold Thickness
Adipose Tissue
Air
Electric Impedance
Adiposity
Odds Ratio
Survival

Keywords

  • body composition assessment
  • body impedance analysis
  • chronic kidney disease
  • epidemiology
  • obesity
  • skinfold thickness

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Diagnosing obesity by body mass index in chronic kidney disease : An explanation for the "obesity paradox?". / Agarwal, Rajiv; Bills, Jennifer E.; Light, Robert P.

In: Hypertension, Vol. 56, No. 5, 11.2010, p. 893-900.

Research output: Contribution to journalArticle

@article{f7972bf3a82540f794c8e7ddfdf0a597,
title = "Diagnosing obesity by body mass index in chronic kidney disease: An explanation for the {"}obesity paradox?{"}",
abstract = "Although obesity is associated with poor outcomes, among patients with chronic kidney disease (CKD), obesity is related to improved survival. These results may be related to poor diagnostic performance of body mass index (BMI) in assessing body fat content. Accordingly, among 77 patients with CKD and 20 controls, body fat percentage was estimated by air displacement plethysmography (ADP), skinfold thickness, and body impedance analysis. Defined by BMI ≥30 kg/m, the prevalence of obesity was 20{\%} in controls and 65{\%} in patients with CKD. Defined by ADP, the prevalence increased to 60{\%} among controls and to 90{\%} among patients with CKD. Although sensitivity and positive predictive value of BMI to diagnose obesity were 100{\%}, specificity was 72{\%}, but the negative predictive value was only 30{\%}. BMI correctly classified adiposity in 75{\%}. Regardless of the presence or absence of CKD, subclinical obesity (defined as BMI <30 kg/m but excess body fat by ADP) was often missed in people with low lean body mass. The adjusted odds ratio for subclinical obesity per 1 kg of reduced lean body mass by ADP was 1.14 (95{\%} CI: 1.06 to 1.23; P<0.001). Skinfold thickness measurements correctly classified 94{\%} of CKD patients, but bioelectrical impedance analyzer-assessed body fat estimation did so in only 65{\%}. Air displacement plethysmography-, skinfold thickness-, and bioelectrical impedance analyzer-assessed body fat all provided reproducible estimates of adiposity. Skinfold thickness measurements may be a better test to classify obesity among those with CKD. Given the low negative predictive value of BMI for obesity, our study may provide an explanation of the {"}obesity paradox.{"}",
keywords = "body composition assessment, body impedance analysis, chronic kidney disease, epidemiology, obesity, skinfold thickness",
author = "Rajiv Agarwal and Bills, {Jennifer E.} and Light, {Robert P.}",
year = "2010",
month = "11",
doi = "10.1161/HYPERTENSIONAHA.110.160747",
language = "English",
volume = "56",
pages = "893--900",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Diagnosing obesity by body mass index in chronic kidney disease

T2 - An explanation for the "obesity paradox?"

AU - Agarwal, Rajiv

AU - Bills, Jennifer E.

AU - Light, Robert P.

PY - 2010/11

Y1 - 2010/11

N2 - Although obesity is associated with poor outcomes, among patients with chronic kidney disease (CKD), obesity is related to improved survival. These results may be related to poor diagnostic performance of body mass index (BMI) in assessing body fat content. Accordingly, among 77 patients with CKD and 20 controls, body fat percentage was estimated by air displacement plethysmography (ADP), skinfold thickness, and body impedance analysis. Defined by BMI ≥30 kg/m, the prevalence of obesity was 20% in controls and 65% in patients with CKD. Defined by ADP, the prevalence increased to 60% among controls and to 90% among patients with CKD. Although sensitivity and positive predictive value of BMI to diagnose obesity were 100%, specificity was 72%, but the negative predictive value was only 30%. BMI correctly classified adiposity in 75%. Regardless of the presence or absence of CKD, subclinical obesity (defined as BMI <30 kg/m but excess body fat by ADP) was often missed in people with low lean body mass. The adjusted odds ratio for subclinical obesity per 1 kg of reduced lean body mass by ADP was 1.14 (95% CI: 1.06 to 1.23; P<0.001). Skinfold thickness measurements correctly classified 94% of CKD patients, but bioelectrical impedance analyzer-assessed body fat estimation did so in only 65%. Air displacement plethysmography-, skinfold thickness-, and bioelectrical impedance analyzer-assessed body fat all provided reproducible estimates of adiposity. Skinfold thickness measurements may be a better test to classify obesity among those with CKD. Given the low negative predictive value of BMI for obesity, our study may provide an explanation of the "obesity paradox."

AB - Although obesity is associated with poor outcomes, among patients with chronic kidney disease (CKD), obesity is related to improved survival. These results may be related to poor diagnostic performance of body mass index (BMI) in assessing body fat content. Accordingly, among 77 patients with CKD and 20 controls, body fat percentage was estimated by air displacement plethysmography (ADP), skinfold thickness, and body impedance analysis. Defined by BMI ≥30 kg/m, the prevalence of obesity was 20% in controls and 65% in patients with CKD. Defined by ADP, the prevalence increased to 60% among controls and to 90% among patients with CKD. Although sensitivity and positive predictive value of BMI to diagnose obesity were 100%, specificity was 72%, but the negative predictive value was only 30%. BMI correctly classified adiposity in 75%. Regardless of the presence or absence of CKD, subclinical obesity (defined as BMI <30 kg/m but excess body fat by ADP) was often missed in people with low lean body mass. The adjusted odds ratio for subclinical obesity per 1 kg of reduced lean body mass by ADP was 1.14 (95% CI: 1.06 to 1.23; P<0.001). Skinfold thickness measurements correctly classified 94% of CKD patients, but bioelectrical impedance analyzer-assessed body fat estimation did so in only 65%. Air displacement plethysmography-, skinfold thickness-, and bioelectrical impedance analyzer-assessed body fat all provided reproducible estimates of adiposity. Skinfold thickness measurements may be a better test to classify obesity among those with CKD. Given the low negative predictive value of BMI for obesity, our study may provide an explanation of the "obesity paradox."

KW - body composition assessment

KW - body impedance analysis

KW - chronic kidney disease

KW - epidemiology

KW - obesity

KW - skinfold thickness

UR - http://www.scopus.com/inward/record.url?scp=78149268616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149268616&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.110.160747

DO - 10.1161/HYPERTENSIONAHA.110.160747

M3 - Article

C2 - 20876448

AN - SCOPUS:78149268616

VL - 56

SP - 893

EP - 900

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 5

ER -